SYIN (Synbio International) Notes Receivable: $0.00 Mil (As of Sep. 2023)


What is Synbio International Notes Receivable?

Synbio International SYIN Notes Receivable is $0.00 Mil as of Sep. 2023.

Synbio International's Notes Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.

Synbio International Notes Receivable Related Terms

Synbio International Notes Receivable Historical Data

* Premium members only.

The historical data trend for Synbio International's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synbio International Notes Receivable Chart

Synbio International Annual Data
Trend Dec20 Dec21 Dec22
Notes Receivable
0.00 0.00 0.00

Synbio International Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23
Notes Receivable Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Synbio International Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Synbio International (SYIN) has a Notes Receivable of $0.00 Mil as of Sep. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Synbio International and its competitors.
Is Synbio International's Notes Receivable too high?
Synbio International's current Notes Receivable is $0.00 Mil.
How does Synbio International's Notes Receivable compare to IVFH and DIT?
Synbio International's Notes Receivable of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Healthcare Providers & Services company?
A good Notes Receivable depends on the Healthcare Providers & Services industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Synbio International and its competitors. Synbio International's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio International stock overvalued right now?
Synbio International (SYIN) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Synbio International (SYIN), the current Notes Receivable is $0.00 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synbio International Business Description

Address 30 N Gould Street, Suite 5835, Sheridan, WY, USA, 82801
Synbio International Inc is a shell company.